Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Genetics is a leading aquaculture biotechnology company specializing in the genetic selection and distribution of high-quality White Shrimp (Litopenaeus vannamei) broodstock. Headquartered in France with its primary production and R&D hub in Mexico, the company utilizes advanced molecular biology and genomic tools to develop Specific Pathogen Free (SPF) strains. Their breeding programs focus on enhancing key performance traits such as rapid growth, high survival rates, and resistance to major aquaculture pathogens like White Spot Syndrome Virus (WSSV) and Early Mortality Syndrome (EMS). As a subsidiary of Groupe Grimaud, Blue Genetics leverages decades of multi-species genetic expertise to provide sustainable and biosecure solutions to the global shrimp farming industry. The company serves a diverse international clientele, providing high-performance genetics that improve yield and efficiency in shrimp hatcheries and farms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Genetics.